Ads
related to: Stelara Used- Register For Savings
Sign Up For Information, Updates,
& A $0 Co-Pay Savings Offer.
- PsO & Psoriatic Arthritis
Learn More About The Connection
& View Patient Resources.
- The PsO & PsA Connection
See The Signs & Symptoms Of PsA
To Look Out For If You Have PsO.
- Clinical Trial Results
Get The Facts On How Treatment
Performed In Clinical Trials Here.
- Plaque Psoriasis In Kids
See A Treatment Option
For Children 6 Years & Older.
- Discussion Guide
Questions To Ask Before Seeing Your
Doctor To Talk About Treatment.
- Register For Savings
Search results
Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast
Reuters via Yahoo Finance· 11 months agoJohnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster...
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 2 years agoAs a healthcare professional, Alison spent her days doing endoscopies, which are one of the many...
J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
Reuters via Yahoo News· 1 year ago(Reuters) -Johnson & Johnson's Janssen unit has sued Amgen Inc over its plan to market a drug for...
J&J's medical device sales fall short, cancer drugs seen growing
Reuters via Yahoo Finance· 1 week ago(Reuters) -Johnson & Johnson's first-quarter revenue missed Wall Street estimates for medical...
Unexpected drugs make first round of Medicare negotiations
The Hill via Yahoo News· 8 months agoThe Centers for Medicare and Medicaid Services (CMS) have officially named the first 10 drugs chosen...
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Motley Fool via Yahoo Finance· 1 month agoJohnson & Johnson (NYSE: JNJ) is one of the leading and most recognizable names in healthcare. It...
U.S. drug price negotiations are underway. Here’s what that will mean for you—eventually
Fortune via Yahoo Finance· 3 months agoNegotiations are underway between the federal government and pharmaceutical companies to determine...
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive via Yahoo Finance· 3 months agoThe CEOs of three major drugmakers defended the prices they charge U.S. patients in a Senate...
Johnson & Johnson forecasts as much as 6% sales growth in 2024
Reuters via Yahoo Finance· 5 months ago(Reuters) -Johnson & Johnson on Tuesday forecast revenue growth of 5-6% for 2024, its first full...
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
Motley Fool via Yahoo Finance· 2 weeks agoJohnson & Johnson (NYSE: JNJ) has focused more on growth initiatives since spinning off its consumer...
Ads
related to: Stelara Used
